Skip to main content

Animations

MJFF Publications

3871 - 3880 of 8761 Results
Title
Year
  • Year
  • 2024
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Synapsin E-domain is essential for α-synuclein function
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.89687.3
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Patients with progressive supranuclear palsy need to be seen sooner and more frequently
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105883
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Autophagy preferentially degrades non-fibrillar polyQ aggregates
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2024.04.018
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00679-1
    Citation Count: 0
  • Summary Details
    OPEN
    Title: TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-024-01610-w
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00714-1
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Deciphering the role of a SINE-VNTR-Alu retrotransposon polymorphism as a biomarker of Parkinson’s disease progression
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-61753-5
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
    Journal Name: Diagnostics
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/diagnostics14090929
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Positron Emission Tomography with [18F]ROStrace Reveals Progressive Elevations in Oxidative Stress in a Mouse Model of Alpha-Synucleinopathy
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25094943
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0000000000000556
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.